menu
    • menu

    Company profile for Vividion Therapeutics

    NEW Drugs in Dev: 3
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Vividion Therapeutics is transforming the future of human health through the creation of highly selective small molecule medicines that drug traditionally inaccessible targets. We are advancing a broad, diversified pipeline of selective small molecule therapeutics for multiple highly sought-after disease-modifying target proteins in oncology and immunology. We are focused on the discovery, development and consolidation of unpr...
    Vividion Therapeutics is transforming the future of human health through the creation of highly selective small molecule medicines that drug traditionally inaccessible targets. We are advancing a broad, diversified pipeline of selective small molecule therapeutics for multiple highly sought-after disease-modifying target proteins in oncology and immunology. We are focused on the discovery, development and consolidation of unprecedented insights and approaches to create small molecule medicines against the most sought-after targets in oncology and immunology.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Vividion TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    5820 Nancy Ridge Drive San Diego, CA 92121
    Telephone
    Telephone
    858.345.4690
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://vividion.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    euroPLX 90 Lisbon

    Not Confirmed

    envelop Contact Supplier

    euroPLX 90 Lisbon

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Vividion Publishes WRN Inhibitor VVD-214 in J. Med. Chem
    Vividion Publishes WRN Inhibitor VVD-214 in J. Med. Chem

    06 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260106463899/en/Vividion-Publishes-Discovery-of-WRN-Inhibitor-VVD-214-in-Journal-of-Medicinal-Chemistry

    BUSINESSWIRE
    06 Jan 2026
    Share Share
    Vividion Unveils First-in-Class KEAP1 Activator for Oncology
    Vividion Unveils First-in-Class KEAP1 Activator for Oncology

    22 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251222362539/en/Vividion-Publishes-Discovery-of-First-in-Class-KEAP1-Activator-Supporting-Ongoing-Clinical-Program-in-Oncology

    BUSINESSWIRE
    22 Dec 2025
    Share Share
    Bayer Bails On Vividion Tumor Drug In Early-Stage Clear-Out
    Bayer Bails On Vividion Tumor Drug In Early-Stage Clear-Out

    12 Nov 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/bayer-bails-vividion-tumor-drug-part-early-stage-cancer-clear-out

    FIERCE BIOTECH
    12 Nov 2025
    Share Share
    Vividion Publishes RAS-PI3K Data Showing Block Tumor Growth
    Vividion Publishes RAS-PI3K Data Showing Block Tumor Growth

    09 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251009963422/en/Vividion-Announces-Publication-in-Science-of-Preclinical-Data-on-Covalent-Inhibitors-of-RAS-PI3K-that-Block-Tumor-Growth

    BUSINESSWIRE
    09 Oct 2025
    Share Share
    Vividion Therapeutics Names Sam Whiting as Chief Medical Officer
    Vividion Therapeutics Names Sam Whiting as Chief Medical Officer

    13 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250813751175/en/Vividion-Therapeutics-Appoints-Sam-Whiting-M.D.-Ph.D.-as-Chief-Medical-Officer

    BUSINESSWIRE
    13 Aug 2025
    Share Share
    Vividion, Bayer Advance Clinical WRN Inhibitor for Oncology
    Vividion, Bayer Advance Clinical WRN Inhibitor for Oncology

    04 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250604147547/en/Vividion-Therapeutics-and-Bayer-Further-Strengthen-Oncology-Development-Pipeline-with-Clinical-Stage-WRN-Inhibitor

    BUSINESSWIRE
    04 Jun 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search